FDA Investigator Mastalskij
Mastalskij has inspections in 1 countries as of 07 Sep 2023. Mastalskij has collaborated with a combined 1441 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
116
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan D Centi,
Alissa E Berryman,
Audrey Thereset Uy,
Austin B Appler,
Beichner,
Brandi L Garbutt,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brian D Young,
Calvin W Edwards,
CDR Michael J Mero,
Chamberlain,
Cynthia White,
Daniel R Tammariello,
Daniel W Johnson,
Darlene C Plank Turlington,
Dauksism,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Debra J Bennett,
Dessa A Antoine,
Donald W Myrick,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Edwin L Hobbs,
Eric S Myskowski,
Erik A Bungo,
Erika M Wilkerson,
Gerald W Kopp,
Gess,
Gladys B Casper,
Gregory E Beichner,
Hamiltonl,
Haney,
James M Mason,
James M Odonnell,
James P Mcevoy,
Jason M Sluzynski,
Joseph L Despins, PhD,
Joseph R Hatcher,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Paterson,
Judith Paterson,
Julianne C Mccullough,
Katelyn Astaub Zamperini,
Kelly N Kerr,
Kirk A Dymbrowski,
Kyle S Hobson,
LCDR Margaret E Digennaro,
LCDR Susan E Polifko,
LCDR William H Bender,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Mary R Kirker,
Matthew R Noonan,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael A Taylor,
Michael D Omeara,
Michele M Falchek,
Myrick,
O'meara,
Raymond L Cheung,
Sean D Duke,
Sharon Ferraro,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Tammy M Phillips,
Thomas E Friel,
Thompsonv,
Timothy J Schmidt,
Todd J Maushart,
Travis R Hunt,
Valerie G Vallely,
Van Cliff,
Whitney S Reynolds,
William C Brenneman
Mastalskij's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2012 | FDA 483 | Pennsylvania Correctional Industries - Form 483, 2012-03-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more